---
figid: PMC4882719__nutrients-08-00307-g002
figlink: /pmc/articles/PMC4882719/figure/nutrients-08-00307-f002/
number: F2
caption: 'Cancer-related cell mechanisms modulated by EGCG: (1) Inhibition of DNA
  hypermethylation by direct blocking of DNA methyltransferase (DNMT); (2) Repression
  of telomerase activity; (3) Inhibition of angiogenesis by repression of transcription
  factors Hypoxia-inducible factor 1-α (HIF-1α) and Nuclear factor kappa B (NF-κB);
  (4) Blocking of cell metastasis by inhibition of Matrix metalloproteinases (MMPs)
  -2, -9 and -3; (5) Promotion of cancer cell apoptosis by induction of pro-apoptotic
  proteins BCL-2-associated X protein (BAX) and BCL-2 homologous antagonist killer
  (BAK) and repression of anti-apoptotic proteins B-cell lymphoma 2 (BCL-2) and B
  cell lymphoma-extra large (BCL-XL); (6) Induction of tumor suppressor genes p53
  and Phosphatase and tensin homolog (PTEN) and inhibition of oncogenes Human epidermal
  growth factor receptor 2 (HER2) and Epidermal growth factor receptor (EGFR); (7)
  Inhibition of NF-κB and subsequent events of cell inflammation, proliferation, metastasis
  and angiogenesis; and (8) Anti-proliferative activity by inhibition of Mitogen-activated
  protein kinases (MAPK) pathway and Insulin-like growth factor I receptor (IGFIR).'
pmcid: PMC4882719
papertitle: Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy.
reftext: Andreia Granja, et al. Nutrients. 2016 May;8(5):307.
pmc_ranked_result_index: '177904'
pathway_score: 0.9733112
filename: nutrients-08-00307-g002.jpg
figtitle: Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy.
year: '2016'
organisms:
- Homo sapiens
ndex: 6e67a80d-dec2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4882719__nutrients-08-00307-g002.html
  '@type': Dataset
  description: 'Cancer-related cell mechanisms modulated by EGCG: (1) Inhibition of
    DNA hypermethylation by direct blocking of DNA methyltransferase (DNMT); (2) Repression
    of telomerase activity; (3) Inhibition of angiogenesis by repression of transcription
    factors Hypoxia-inducible factor 1-α (HIF-1α) and Nuclear factor kappa B (NF-κB);
    (4) Blocking of cell metastasis by inhibition of Matrix metalloproteinases (MMPs)
    -2, -9 and -3; (5) Promotion of cancer cell apoptosis by induction of pro-apoptotic
    proteins BCL-2-associated X protein (BAX) and BCL-2 homologous antagonist killer
    (BAK) and repression of anti-apoptotic proteins B-cell lymphoma 2 (BCL-2) and
    B cell lymphoma-extra large (BCL-XL); (6) Induction of tumor suppressor genes
    p53 and Phosphatase and tensin homolog (PTEN) and inhibition of oncogenes Human
    epidermal growth factor receptor 2 (HER2) and Epidermal growth factor receptor
    (EGFR); (7) Inhibition of NF-κB and subsequent events of cell inflammation, proliferation,
    metastasis and angiogenesis; and (8) Anti-proliferative activity by inhibition
    of Mitogen-activated protein kinases (MAPK) pathway and Insulin-like growth factor
    I receptor (IGFIR).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK11
  - MAPK10
  - VEGFB
  - VEGFC
  - MAPK13
  - MAPK12
  - BCL2L1
  - MAPK9
  - MAP2K6
  - MMP9
  - MAP2K7
  - MAPK8
  - BAK1
  - BAX
  - BCL2
  - DNMT1
  - VEGFD
  - EGFR
  - MAP2K1
  - NFKB1
  - MMP2
  - MMP3
  - MAP2K5
  - MAPK3
  - MAP2K4
  - MAPK14
  - MAPK1
  - VEGFA
  - ERBB2
  - MAP2K2
  - PGF
  - IGF1R
  - TP53
  - MAP2K3
  - PTEN
  - Lung cancer
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: BCL-XL
  symbol: bcl-xL
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAP2K-
  symbol: MAP2K
  source: bioentities_symbol
  hgnc_symbol: MAP2K6
  entrez: '5608'
- word: MMP-9
  symbol: MMP9
  source: hgnc_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: MAP2K-
  symbol: MAP2K
  source: bioentities_symbol
  hgnc_symbol: MAP2K7
  entrez: '5609'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: BAK
  symbol: BAK
  source: hgnc_alias_symbol
  hgnc_symbol: BAK1
  entrez: '578'
- word: BAX
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: BCL-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: '''DNMT'
  symbol: DNMT
  source: hgnc_prev_symbol
  hgnc_symbol: DNMT1
  entrez: '1786'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: EGFR)
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: MAP2K-
  symbol: MAP2K
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: MMP-2
  symbol: MMP2
  source: hgnc_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: MMP-3
  symbol: MMP3
  source: hgnc_symbol
  hgnc_symbol: MMP3
  entrez: '4314'
- word: MAP2K-
  symbol: MAP2K
  source: bioentities_symbol
  hgnc_symbol: MAP2K5
  entrez: '5607'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAP2K-
  symbol: MAP2K
  source: bioentities_symbol
  hgnc_symbol: MAP2K4
  entrez: '6416'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: (HER2,EGFR)
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: MAP2K-
  symbol: MAP2K
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: IGF-IR
  symbol: IGFIR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: (p53,PTEN)
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: MAP2K-
  symbol: MAP2K
  source: bioentities_symbol
  hgnc_symbol: MAP2K3
  entrez: '5606'
- word: PTEN)
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
chemicals: []
diseases:
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC4882719__F2
redirect_from: /figures/PMC4882719__F2
figtype: Figure
---
